China SXT Pharmaceuticals, Inc. announced that it has entered into a securities purchase agreement with Streeterville Capital, LLC for an unsecured promissory note for gross proceeds of $2,000,000 on March 7, 2023. The note is convertible into ordinary shares, $0.08 par value per share, of the company. The note bears interest at a rate of 6% per annum compounding daily.

The note is redeemable. All outstanding principal and accrued interest on the note will become due and payable twelve months after the purchase price of the note is delivered by Purchaser to the Company. The original principal amount is $ 2,126,666.6. The note includes an original issue discount of $126,666.67 along with $20,000.00 for Investor's fees, costs and other transaction expenses incurred in connection with the purchase and sale of the Note.

The issuances of the Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933.